1.Withania somnifera: a kind of food-medicine plant popular in world in recent years.
Yue WANG ; Kai-Lin YANG ; Chun-Nian HE ; Pei-Gen XIAO
China Journal of Chinese Materia Medica 2021;46(20):5159-5165
Withania somnifera, also known as Indian ginseng, is an important traditional medicine in the Ayurvedic medical system of India, which has a significant effect of adaptation. Modern studies have shown that the main chemical components of W. somnifera are withanolides, which have antioxidant, anti-tumor, enhancing immunity, cardiovascular protection, neuroprotection, anti-stress, anti-stress reaction and hypoglycemic activities. Studies on human, animal, mutagenesis, genotoxicity, reproductive toxicity and drug interaction showed that W. somnifera had good safety. Clinical trials have proved that W. somnifera is effective in treating a variety of human diseases. As a famous traditional medicine and modern dietary supplement, it has a high reputation and market in the international health product market, but in China, there is little scientific research, market development, product introduction and application. In this paper, the traditional application, chemical composition, pharmacological activity, safety evaluation and clinical study of the plant were introduced, so as to increase the understanding of the dual use of the plant, and to provide reference for the future introduction of the product, the service to the health of the Chinese people and the promotion of the "double cycle" of the trade of health products between China and the international community.
Animals
;
China
;
Humans
;
Neoplasms
;
Plant Extracts
;
Withania
;
Withanolides
2.Plant regeneration of Withania somnifera.
Zhengwei LUO ; Yiming SUN ; Cuiping LV ; Fengying WANG ; Jiwei SUN ; Min SUN
China Journal of Chinese Materia Medica 2012;37(7):897-900
OBJECTIVETo study tissue culture and plant regeneration of Withania somnifera.
METHODLeaves of W. somnifera were used for explants, effects of different plant growth substances on callus and shoot induction were studied, different medium and plant growth substances for rooting induction was optimized.
RESULT AND CONCLUSIONThe best plant growth substances combination for callus induction was MS + 1.0 mg x L(-1) 2,4-D + 0.1 mg x L(-1) KT. The optimal medium for germination was MS + 1.0 mg x L(-1) 6-BA + 0.1 mg x L(-1) NAA. The best medium and plant growth substances combination for rooting induction was 1/2MS + 0.5 mg x L(-1) NAA, transplant survival rate of plantlet reached 92% in humus soil-pearlite (1:1).
Culture Media ; pharmacology ; Plant Growth Regulators ; pharmacology ; Regeneration ; drug effects ; Tissue Culture Techniques ; Withania ; drug effects ; growth & development
3.Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional Activity.
Journal of Cancer Prevention 2015;20(3):185-192
BACKGROUND: Withania somnifera (known as Ashwagandha) is a medicinal plant used in the ayurvedic medicines in India. Withaferin-A, a withanolide derived from the leaf extract of W. somnifera, has been reported to exhibit anti-tumor activity against various cancer cells, such as leukemia, breast cancer and colon cancer cells. METHODS: We investigated the anti-cancer effects of withaferin-A on the proliferation and migration of human colorectal cancer (HCT116) cells. And we evaluated the effects of withaferin-A on the transcriptional activity of STAT3 and the growth of HCT116 cells in xenograft mouse tumor model. RESULTS: In the present study, we found that withaferin-A inhibited the proliferation and migration of HCT116 cells in a concentration-dependent manner. Treatment of HCT116 cells with withaferin-A attenuated interleukin-6-induced activation of STAT3, which has been implicated in the development and progression of colon cancer. To examine the effect of withaferin-A on HCT116 cells proliferation in vivo, we generated HCT116 cells xenograft tumors in Balb/c nude mice and treated the tumor bearing mice with or without withaferin-A intraperitoneally. Treatment with withaferin-A exhibited significant decrease in the volume and weight of tumors as compared to untreated controls. CONCLUSIONS: The present study suggests that withaferin-A holds the potential to be developed as a small molecule inhibitor of STAT3 for the treatment of HCT116.
Animals
;
Breast Neoplasms
;
Colon*
;
Colonic Neoplasms*
;
Colorectal Neoplasms
;
HCT116 Cells
;
Heterografts
;
Humans
;
India
;
Leukemia
;
Mice
;
Mice, Nude
;
Plants, Medicinal
;
STAT3 Transcription Factor
;
Withania
4.Hair roots induction and culture of Withania somnifera and its withanolide A synthesis.
Feng-Ying WANG ; Yi-Ming SUN ; Cui-Ping LV ; Meng-Qi CHENG ; Lai ZHANG ; Min SUN
China Journal of Chinese Materia Medica 2014;39(5):790-794
Withanolide A is a biologically active secondary metabolite occuring in roots and leaves of Withania somnifera. In the present study, adventitious roots from leaf explants of W. somnifera were induced for the production of withanolide-A by Agrobacterium tumefaciens strain C58C1 to obtain hair roots. Hair roots induction rate reached 30%. The withanolide A was determined by HPLC in different hair roots lines and different parts of W. somnifera. The average content of withanolide A in all hair roots lines were 1.96 times as high as that in wild-plant, the concentration of withanolide A in hair roots (1.783 mg x g(-1) dry weight) were 1.51 times as high as the roots of wild W. somnifera (1.180 mg x g(-1) dry weight), respectively. It is possible to obtain withanolide A from hair roots culture of W. somnifera.
Agrobacterium tumefaciens
;
physiology
;
Plant Extracts
;
analysis
;
biosynthesis
;
Plant Roots
;
chemistry
;
growth & development
;
metabolism
;
microbiology
;
Withania
;
chemistry
;
growth & development
;
metabolism
;
microbiology
;
Withanolides
;
analysis
;
metabolism
5.Withaferin A Inhibits Helicobacter pylori-induced Production of IL-1beta in Dendritic Cells by Regulating NF-kappaB and NLRP3 Inflammasome Activation.
Jae Eun KIM ; Jun Young LEE ; Min Jung KANG ; Yu Jin JEONG ; Jin A CHOI ; Sang Muk OH ; Kyung Bok LEE ; Jong Hwan PARK
Immune Network 2015;15(6):269-277
Helicobacter pylori infection is associated with chronic gastritis, peptic ulcer, and gastric cancer. There is evidence that IL-1beta is associated with the development of gastric cancer. Therefore, downregulation of H. pylori-mediated IL-1beta production may be a way to prevent gastric cancer. Withaferin A (WA), a withanolide purified from Withania somnifera, is known to exert anti-inflammatory and anti-tumor effects. In the present study, we explored the inhibitory activity of WA on H. pylori-induced production of IL-1beta in murine bone marrow-derived dendritic cells (BMDCs) and the underlying cellular mechanism. Co-treatment with WA decreased IL-1beta production by H. pylori in BMDCs in a dose-dependent manner. H. pylori-induced gene expression of IL-1beta and NLRP3 (NOD-like receptor family, pyrin domain containing 3) were also suppressed by WA treatment. Moreover, IkappaB-alpha phosphorylation by H. pylori infection was suppressed by WA in BMDCs. Western blot analysis revealed that H. pylori induced cleavage of caspase-1 and IL-1beta, as well as increased procaspase-1 and pro IL-1beta protein levels, and that both were suppressed by co-treatment with WA. Finally, we determined whether WA can directly inhibit ac tivation of the NLRP3 inflammasome. NLRP3 activators induced IL-1beta secretion in LPS-primed macrophages, which was inhibited by WA in a dose-dependent manner, whereas IL-6 production was not affected by WA. Moreover, cleavage of IL-1beta and caspase-1 by NLRP3 activators was also dose-dependently inhibited by WA. These findings suggest that WA can inhibit IL-1beta production by H. pylori in dendritic cells and can be used as a new preventive and therapeutic agent for gastric cancer.
Blotting, Western
;
Caspase 1
;
Dendritic Cells*
;
Down-Regulation
;
Gastritis
;
Gene Expression
;
Helicobacter pylori
;
Helicobacter*
;
Humans
;
Interleukin-1beta
;
Interleukin-6
;
Macrophages
;
NF-kappa B*
;
Peptic Ulcer
;
Phosphorylation
;
Stomach Neoplasms
;
Withania